Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MEDICAL DEVICE LABELING CLAIMS: BROAD VERSUS SPECIFIC INDICATIONS

This article was originally published in The Gray Sheet

Executive Summary

MEDICAL DEVICE LABELING CLAIMS: BROAD VERSUS SPECIFIC INDICATIONS for use will be addressed in a forthcoming policy statement currently in the works at the Center for Devices and Radiological Health's Office of Device Evaluation. Speaking Sept. 20 at the annual meeting of the Regulatory Affairs Professionals Society in Washington, D.C., ODE Director Susan Alpert, MD, PhD, said the agency's policy is "under development and I expect that you'll hear something on that within the next few months."

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002861

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel